공시 • Jan 18

BYND Cannasoft Enterprises Inc. Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device

BYND Cannasoft Enterprises Inc. announced that in addition to the US Provisional Patent Application with serial number 63/297,009 that was filed on January 6, 2022, covering the monitoring and controlling aspects of its EZ-G device, the company filed a full-scale PCT application on January 5, 2023, under serial number PCT/IL2023/050016. The PCT application is based on BYND Cannasoft’s prototype of the EZ-G device that is currently under development and its operational aspects as a learning adult device. The PCT application further claims priority from the US Provisional application and covers an adult device with a structure and one or more moving and vibrating elements. In addition to potentially treating annoying phenomena in the female reproductive system, the EZ-G device includes technological advancements as a sex toy with a more realistic experience. The EZ-G device prototype uses sensors like a pressure sensor, temperature sensor, conductivity sensor, and heart rate sensor to determine what specifically enhances the users' pleasure. The EZ-G device uses artificial intelligence (AI) to transmit and receive data from the device's sensors on conditions of the user's sexual organs, such as moisture levels and pressure variations due to muscle contraction. The EZ-G prototype includes a Bluetooth component for controlling the adult device via an app installed on a smartphone or other portable device to collect user information about preferences and generate custom programs. The data collected from the sensors is uploaded to the secured cloud, where it is combined with other antonymic user's preferences, including the actual duration of operation of the adult device, lubrication level, and the ideal vibration level. This information optimizes the operation of the device to satisfy the user sexually. The EZ-G device uses the collected secured data to learn the users' responses and improve its operation to bring the user sexual satisfaction. Wearable tech has seen tremendous growth in recent years. When most people think of wearables, they think of fitness trackers and smartwatches, but there is also an emerging trend in wearable sex toys. The excitement of a sex toy and the thrill of clandestine public stimulation have contributed to this trend. Cannasoft intends to take advantage of the growth in the sextech market, which is expected to reach $62.32 by 2030. According to Forbes, companies are working to innovate products that have an intelligent response for sexual activity to take advantage of this expected growth.

Seeking Alpha • Sep 13

BYND Cannasoft: New CRM Platform Disrupts The Medical Cannabis Industry

Summary BYND Cannasoft Enterprises Inc. has been marketing its proprietary CRM software known as Benefit CRM to approximately 400 clients with a monthly recurring revenue model for close to 20 years. BYND Cannasoft Enterprises could be entering a phase of unprecedented growth as it introduces its new CRM platform to meet the needs of the medical cannabis industry. According to the Israeli Medical Cannabis Agency, as of November 2021, Israel had 110,000 medical cannabis license holders. In addition to helping cannabis growers manage their day-to-day business activities, BYND Cannasoft's New Cannabis CRM Platform could ultimately become the "virtual marketplace" for all stakeholders in medical cannabis. BYND Cannasoft Enterprises Inc. (BCAN, BYND.CA) has been marketing its proprietary customer relationship management (CRM) software product known as Benefit CRM to approximately 400 clients with a monthly recurring revenue model for close to 20 years. BYND Cannasoft Enterprises' Benefit CRM software enables small and medium-sized businesses to optimize their day-to-day business activities, such as sales management, personnel management, marketing, call center activities, and asset management. Benefit 2.0 software is an advanced generation of cloud database management software currently used by dozens of the company's clients in Israel. According to BYND Cannasoft Enterprises' Storydoc website, current customers include Soreq Nuclear Research Center and Harel Insurance Investments and Financial Services Ltd. Soreq Nuclear Research Center is Israel's nuclear reactor. Harel Insurance Investments is one of the most comprehensive insurance and financial services companies in Israel, with more than 80 years of insurance experience. Others include the Ness Group, One for Israel, and Perrigo Israel Pharmaceuticals Ltd. Ness is a private company that provides comprehensive computing services in the business and educational sectors. One for Israel is an Israeli-based IT company employing nearly 4,000 experts in Israel and globally to provide computer-based solutions to more than 2,000 clients and tens of thousands of users. Perrigo Israel develops, manufactures, and markets Generic Pharmaceuticals and Active Pharmaceutical ingredients. It has three manufacturing sites worldwide. BYND Cannasoft Enterprises Current Customers Incude Some of Israel's Largest Companies (Company website) Medical Cannabis CRM Software Building on its 20 years of experience in CRM software, BYND Cannasoft Enterprises recently began the development of a new CRM platform designed to serve the needs of the medical cannabis industry. BYND Cannasoft Enterprises is looking to transform the sector into a more organized, accessible, and price transparent market. BYND Cannasoft's goal is that its New Cannabis CRM Platform will ultimately become the "virtual marketplace" for all stakeholders in medical cannabis, which is similar to what Jack Ma did with Alibaba (BABA). In addition to the virtual marketplace, the CRM and ERP system will allow growers a deep insight into all aspects of managing a cannabis farm and cannabis distribution, from the amounts of fertilizer to tracking delivery revenue. The ERP system will help cannabis growers manage their day-to-day business activities like supply chain operations, accounting, procurement, project management, risk management, and compliance. BYND Cannasoft's medical cannabis software has completed its first development phase and is currently installed in one entity in this field in Israel. Cannabis stocks have had a mixed year, led by companies like Aurora Cannabis (ACB), Canopy Growth Corp (CGC), and Cronos Group (CRON). However, BYND Cannasoft could provide a boost to the industry as its CRM platform catches on. This new platform could be a first for the medical cannabis field. Cannabis growers have been affected by the covid-19 pandemic and the war in Ukraine. Since Ukraine and Russia export 28% of the world's fertilizers, supply chains have been upset by war and economic sanctions. During the pandemic, consumers spent more money on cannabis than ever before, which meant growers had to produce a lot more cannabis to meet demand. Cannabis sales increased during the covid-19 pandemic, as many people were homebound. Now that the pandemic is winding down and people are returning to work, supply outweighs the current demand for cannabis. If you remember back to introductory economics, we generally see a price decline if supply is more significant than demand. Lower prices do not necessarily mean growers need to throw in the towel on their cannabis crops, but they need to be more aware of their costs and inventory, which is where BYND Cannasoft Enterprises comes in. BCAN data by YCharts Cannabis Farm BYND Cannasoft Enterprises has a growing license in Israel, and it has been working with the Bezinzsky family (a medical cannabis license holder) to establish a medical cannabis farm. The company has made the following progress: It is currently working on transferring the initial permit for the cultivation and multiplication of medical cannabis according to the partnership agreement with the Bezinsky family. After its transfer, the company will operate for the planning and construction of a growing facility in Moshav Kochav Michael. The company has completed the planning and placement of an internal breeding facility and has applied for a breeding license. BYND Cannasoft Enterprises has applied for a license to trade in medical cannabis "without contact with the substance," also known as a constructive license. After receiving the permit, the company can implement agreements it has signed with various growers for marketing and selling the company's private label. BYND Cannasoft Enterprises plans to develop its cannabis farm near Ashkelon, Israel, on 3.5 acres (15 dunams) of land with an option to expand the farm to twice that size. The IMC-GDP license is an exclusive license issued by the Ministry of Health - The Israeli Medical Cannabis Unit for importing, distributing, and storing cannabis for medical use in a designated facility. BYND Cannasoft Enterprises aims to receive the IMC-GMP licenses within the year and will mainly export to Germany once regulation permits. BYND Cannasoft Enterprises is in the final stages of obtaining its license. Immediately after receiving its license, the company management said it would have products on the shelves. During this time, BYND Cannasoft Enterprises has obtained a separate license that allows the company to enter into a contract with one of the existing growers in Israel to build a private label of products for the company. BYND Cannasoft Enterprises intends to market these products to pharmacies to generate revenues without the required investment in establishing and operating a growing facility. The agreement with the grower includes marketing in Israel and the marketing of BYND Cannasoft Enterprises' brand to Germany through the grower's growing farm in Uganda. BYND Cannasoft Enterprises’ plans include the construction of 4 state-of-the-art greenhouses, housing approximately 2.5 acres of total growing area. The company estimates that, once fully operational, its Cannabis farm facility will be able to produce 7,500 kg, or 16,534 pounds, of raw cannabis each year. BYND Cannasoft Enterprises also intends to work with strategic partners to develop and market proprietary cannabis-infused products for the Israeli and global markets. The data and information collected through the operation of the cannabis farm and the products it produces will also allow BYND Cannasoft Enterprises to test its new Cannabis CRM platform and adjust the platform as necessary. BYND Cannasoft Enterprises' long-term goal is to leverage its cannabis farm business to assist in developing its New Cannabis CRM Platform. Utilizing data from growing, harvesting, and selling medical cannabis at its cannabis farm, BYND Israel can optimize its New Cannabis CRM Platform to offer stakeholders in the Cannabis industry a state-of-the-art resource that will enhance their businesses. Q2 2022 Financial Highlights According to an August 12, 2022 press release, BYND Cannasoft Enterprises reported financial results for the six months ending June 30, 2022. Complete versions of BYND Cannasoft Enterprises' financial statements can be found on www.sedar.com. As a result of the move toward its cannabis CRM platform, BYND Cannasoft Enterprises posted revenue of $662,932 for the first half of 2022, compared with $662,728 for the same period in 2021. Gross Profit increased to 59% for the first half of 2022 from 48% for the same period in 2021. Net loss decreased 86% to $638,669 for the first half of 2022 from $4,543,591 for the same period in 2021. Working capital decreased to 3,988,467 for June 30, 2022 from $5,487,201 for December 31,2021. The total number of shares outstanding as of June 30, 2022, was 29,670,083. Below is a Table Listing a Summary of the Quarterly Comparison of Revenue, Gross Profit, and Net Income (Loss) taken from the August 12, 2022 press release Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Revenue $207,653 $455,279 $258,303 $296,428 $418,635 $244,093 Gross Profit $37,657 $355,111 $126,591 $157,439 $260,167 $78,941 Net Income (Loss) $(473,386) $(165,283) $(271,932) $(59,279) $(103,753) $(4,443,774)* *Includes a one-time non-recurring non-cash $4,394,390 listing expense incurred due to the Business Combination Transactions and the company’s listing of its shares on the CSE. Management The following management bios have been consolidated from BYND Cannasoft Enterprises’ Storydoc website. Moti Maram President and Director In 1986, Mr. Maram partnered to found a computer company that mainly provided services to EXATEC-compliant IBM AS 400 computers and sales and service to the first PCs in the world. After identifying a need for CRM and ERP software, Maram and his partner, Avner Tal, established a software company that manufactures CRM and ERP management software called BENEFIT in 2000. Yftah Ben Yaackov CEO and Director Mr. Yaackov has been a professional lawyer since 2004. He specialized in real estate-related issues, including real estate corporations, complex sales transactions, real estate unions, and real estate taxation. His recent experience includes managing large projects exceeding tens of thousands of square meters with budgets exceeding 400 million NIS ($115 million). Over the last five years, Mr. Yaackov has assembled the business activity of two of the largest medical cannabis companies in Israel, providing him with tremendous experience and knowledge in this field. Avner Tal VP Sales & Marketing, CTO, and Director Mr. Tal currently serves as the Technology Director of Beyond Solution Company. After studying electronics and control, he served in the Navy on the team that implemented and developed the technology that included "smart" missiles. He came to BYND Cannasoft Enterprises after working with Moti Maram to establish the computer company that supported Exatech computers and its innovative network. Gabi Kabazo CFO and Director Gabi is a seasoned finance and operations professional with over 20 years of experience supporting accounting, finance, and IT operations in complex corporate settings. Since 2009, Mr. Kabazo has been with TELUS Telecommunications Company. From 2002-2011 he served as CFO for m-Wise Inc. He received B.A from TAU and M.B.A from UBC in Accounting & Economics. Dr. Stefánia Szabó Director

이자보상배율	n/a
현금	CA$15.23m
자본	CA$35.00m
총부채	CA$872.71k
총자산	CA$35.87m

데이터	최종 업데이트 (UTC 시간)
기업 분석	2026/05/26 00:29
종가	2026/05/19 00:00
수익	2025/12/31
연간 수익	2025/12/31

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

Femto Technologies 대차대조표 건전성

재무 건전성 기준 점검 6/6

핵심 정보

최근 재무 건전성 업데이트

Femto Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Femto Technologies Announces Reverse Split to Regain Compliance with the Nasdaq Minimum Bid Price Requirement

BYND Cannasoft Enterprises Receives Approval for Voluntary Delisting of its Common Shares from CSE

Recent updates

Femto Technologies Inc., Annual General Meeting, Apr 02, 2025

Femto Technologies Inc. announced that it expects to receive $17 million in funding

Femto Technologies Inc. to Showcase Its Innovative Product At ShowStoppers CES

Femto Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Femto Technologies Announces Reverse Split to Regain Compliance with the Nasdaq Minimum Bid Price Requirement

BYND Cannasoft Enterprises Receives Approval for Voluntary Delisting of its Common Shares from CSE

BYND Cannasoft Enterprises Inc. has completed a Composite Units Offering in the amount of $7 million.

BYND Cannasoft Enterprises Inc., Annual General Meeting, May 08, 2024

BYND Cannasoft Enterprises Inc. Appoints Mor Bzizinsky to the Board of Directors

New major risk - Market cap size

Third quarter 2023 earnings released: CA$0.037 loss per share (vs CA$0.011 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.016 loss in 2Q 2022)

New major risk - Share price stability

BYND Cannasoft Enterprises Inc. has completed a Follow-on Equity Offering in the amount of $2.600001 million.

BYND Cannasoft Enterprises Inc. Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization

First quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.006 loss in 1Q 2022)

BYND Cannasoft Enterprises Inc. Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device

Less than half of directors are independent

Third quarter 2022 earnings released: CA$0.011 loss per share (vs CA$0.002 loss in 3Q 2021)

BYND Cannasoft Enterprises announces $649,500 private placement

BYND Cannasoft: New CRM Platform Disrupts The Medical Cannabis Industry

Second quarter 2022 earnings released: CA$0.016 loss per share (vs CA$0.006 loss in 2Q 2021)

Less than half of directors are independent

재무 상태 분석

부채/자본 비율 추이 및 분석

대차대조표

건전한 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터 소스

분석 모델 및 스노우플레이크

산업 및 섹터 지표

분석가 소스